|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM244057311 |
| 003 |
DE-627 |
| 005 |
20240610234056.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2014.10.005
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1435.xml
|
| 035 |
|
|
|a (DE-627)NLM244057311
|
| 035 |
|
|
|a (NLM)25451159
|
| 035 |
|
|
|a (PII)S1521-6616(14)00241-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Kleinnijenhuis, Johanneke
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a BCG-induced trained immunity in NK cells
|b Role for non-specific protection to infection
|
| 264 |
|
1 |
|c 2014
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 19.02.2015
|
| 500 |
|
|
|a Date Revised 10.06.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2014 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Adaptive features of innate immunity, also termed 'trained immunity', have recently been shown to characterize monocytes of BCG vaccinated healthy volunteers. Trained immunity leads to increased cytokine production in response to non-related pathogens via epigenetic reprogramming of monocytes. Recently, memory-like properties were also observed in NK cells during viral infections, but it is unknown if memory properties of NK cells contribute to trained immunity due to BCG vaccination. BCG vaccination of healthy volunteers increased proinflammatory cytokine production following ex vivo stimulation of NK cells with mycobacteria and other unrelated pathogens up until at least three months after vaccination. In addition, in a murine model of disseminated candidiasis, BCG vaccination led to an increased survival in SCID mice, which was partially dependent on NK cells. These findings suggest that NK cells may contribute to the non-specific (heterologous) beneficial effects of BCG vaccination
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a BCG
|
| 650 |
|
4 |
|a Innate immunity
|
| 650 |
|
4 |
|a Trained immunity
|
| 650 |
|
4 |
|a Vaccination
|
| 650 |
|
7 |
|a Antigens, CD
|2 NLM
|
| 650 |
|
7 |
|a BCG Vaccine
|2 NLM
|
| 650 |
|
7 |
|a Cytokines
|2 NLM
|
| 650 |
|
7 |
|a Inflammation Mediators
|2 NLM
|
| 650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
| 650 |
|
7 |
|a 82115-62-6
|2 NLM
|
| 700 |
1 |
|
|a Quintin, Jessica
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Preijers, Frank
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Joosten, Leo A B
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jacobs, Cor
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xavier, Ramnik J
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a van der Meer, Jos W M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a van Crevel, Reinout
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Netea, Mihai G
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 155(2014), 2 vom: 30. Dez., Seite 213-9
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:155
|g year:2014
|g number:2
|g day:30
|g month:12
|g pages:213-9
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2014.10.005
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 155
|j 2014
|e 2
|b 30
|c 12
|h 213-9
|